1 0

    FDA Adverse Event: Full Adverse Event Reports - Izervay (2004-2024)

    FDA Adverse Event: Full Adverse Event Reports - Izervay (2004-2024)

    $89.00 USD
    $89.00 USD
    Sale Sold out
    Request Content: Full adverse event reports for Izervay (avacineaptad pegol intravitreal solution) marketed by Astellas Pharma, Inc., covering September 26, 2004 to December 23, 2024 or the date searched.
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details